Economic growth forecasts of 3.4% for 2011 remain around the long-term average.
Ardevora has begun promoting its UK Equity fund, unveiling a number of long and short positions taken since its launch in February.
Andy Brough has reduced the number of holdings in his £1.6bn UK Mid 250 fund as he looks to concentrate his portfolio around core positions.
Morgan Stanley has been dubbed 'the new Morgan Sachs' after its equity and bond traders captured market share from rivals over the past quarter.
Manager of SVM UK Opportunities sells out of winning stocks before they peak.
Castlestone has released a new statement emphasising the FSA's ongoing investigation into the firm does not relate to any criminal activity.
FSA chief executive Hector Sants insists the regulator is considering the Treasury Select Committee's recommendations on the RDR, following an angry letter from TSC chairman Andrew Tyrie.
Income stars such as Neil Woodford and Bill Mott are set for boosts to their portfolios as AstraZeneca jumped over 3% this morning following the approval of a drug the pharma giant pinned $2bn of future sales.